I

Intuitive Surgical

Builds robots for minimally invasive surgery

ML Engineering Intern

Summer 2026Updated
No salary listed
Internship
Master's, PhD
Norcross, GA, USA
In Person
AI & Machine LearningApplied Machine Learning

About the job

Requirements
  • University Hiring Program Eligibility Requirements: University Enrollment: Must be currently enrolled in and returning to an accredited degree-seeking academic program after the internship.
  • Internship Work Period: Must be available to work full-time (approximately 40 hours per week) during a 10-12 week period starting May or June. Specific start dates are shared during the recruiting process.
  • Required Education and Training: Current enrollment in an Computer Science, Computer Engineering, Electrical & Computer Engineering, or related degree-seeking program at the Master’s, or Doctorate level.
  • Excellent communication skills both written and verbal
  • A desire to work in a high-energy, focused, small-team environment with a sense of shared responsibility and shared reward
  • Interest in early research and development through to product roll-out in the fields of surgical AI and surgical robotics
  • Hands-on experience with ML frameworks, such as PyTorch, Tensorflow, or similar
  • Knowledgeable about MLOps platforms and/or ML CI/CD workflows to manage datasets and model training, deployment, and monitoring
  • Experience with MLOps tools like MLFlow, KubeFlow, W&B, etc
  • Knowledgeable on cloud compute environments such as AWS, GCP, etc
  • Experience with Python and SQL
  • Experience with Git e.g github, gitlab, bitbucket, etc
Responsibilities
  • Working closely with Machine Learning and Data/Software Engineering teams to develop efficient processes for model development/deployment for various applications.
  • Developing automated workflows and tools to curate datasets and facilitate training of deep learning models
  • Integrating machine learning into digital products and services by working cross-functionally across engineering, data science, and machine learning teams
Desired Qualifications
  • Knowledgeable in launching ML models into production
  • Experience supporting large multi-modality dataset including image/video
  • Experience in developing ML applications within healthcare

About the company

Intuitive Surgical makes da Vinci robots that let surgeons operate through a few small incisions, and Ion, a robot that reaches deep into the lungs to take tissue samples. In 2000, da Vinci became the first robotic system cleared by the FDA for general laparoscopic surgery, meaning keyhole operations in the abdomen. A surgeon sits at a nearby console and steers robotic arms holding a 3D camera and wristed instruments, which turn hand movements into smaller, steadier motions. Hospitals buy or lease the robots, then keep paying for the instruments used in each operation and for service. Intuitive was founded in 1995 to commercialize robotic surgery research from SRI International and is based in Sunnyvale, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, CA

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand keeps compounding: da Vinci procedures grew 15% and revenue 19%, to $2.89 billion, in the June 2026 quarter.
  • Room to grow: Intuitive listed 748 open roles in October 2026, including 191 in engineering and 312 in Sunnyvale.
  • Repeat sales steady the business: instruments and service made 76% of revenue in the June 2026 quarter.

What critics are saying

  • Stock grants have shrunk: shares fell 27% from January to October 2026, versus 9% for rival Medtronic.
  • Device giants are moving in: the FDA cleared rival robots from Medtronic in December 2025 and J&J in July 2026.
  • Instrument sales face a court fight: in August 2026, an appeals court revived a repair firm's monopoly suit against Intuitive.

What makes Intuitive Surgical unique

  • Hospitals rent more than they buy: 254 of 468 da Vinci systems placed in the June 2026 quarter were leases.
  • It runs without borrowing: Intuitive had no debt and $8.6 billion in cash and investments in June 2026.
  • Its CEO is a 30-year insider: Dave Rosa, CEO since July 2025, joined as employee number nine in 1996.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Nov 2nd, 2026
Intuitive appoints Humana's Aaron Martin to board, expanding it to 11 members

Intuitive, the maker of robotic surgery systems, has appointed Aaron Martin to its board of directors, effective January 1, 2027. Martin is president of insurance at Humana. His arrival expands the board from 10 to 11 members. Martin spent almost four years at Amazon as vice president of healthcare, where he launched Amazon Clinic, the company's first message and video-based telehealth platform. Before that, he was chief digital officer at Providence St. Joseph Health, a $26 billion not-for-profit health system. There he founded Providence Ventures, a $300 million corporate venture fund with 27 portfolio companies. Chief executive officer Dave Rosa said Martin's experience will help Intuitive expand access to minimally invasive care globally.

Yahoo Finance
Nov 2nd, 2026
Intuitive Surgical plans 3% to 5% da Vinci instrument price cut as $1.8B Q3 sales grow 18%

Intuitive Surgical plans to cut da Vinci instrument prices, which management expects to lower instrument revenue per procedure by about 3% to 5% once fully in place. Instruments and accessories brought in $1.8 billion of the company's $3.05 billion third-quarter 2026 revenue. A billing-code change will sharply reduce prices in China from November. Elsewhere, cuts target high-volume operations such as hernia repair and roll out country by country from the first half of 2027. Revenue per procedure rose to about $1,860 from $1,800 a year earlier, so the cut could erase a year of gains. Management narrowed its 2026 procedure growth forecast to 14% to 15%. US procedures grew 10%, against 20% elsewhere. The shares are down 19.6% over the year to October 30, 2026.

Yahoo Finance
Oct 28th, 2026
Intuitive Surgical at $445.88: 36% overvalued by one model, undervalued by another

Intuitive Surgical's latest earnings showed higher quarterly revenue but lower net income and earnings per share. Its shares trade at $445.88, up 26.32% over 90 days and 7.50% over 30 days. Over longer periods the picture is weaker. The stock is down 20.66% this year, and one-year total shareholder return is down 17.06%. Valuation views differ. One community narrative puts fair value at $327.67, making the shares 36% overvalued. It assumes 14.7% annual revenue growth and a 25% long-term net profit margin, against 28.45% now. A Simply Wall St discounted cash flow model estimates value at $468.27, which suggests the shares are 4.8% undervalued.

Yahoo Finance
Oct 26th, 2026
Intuitive Surgical trades at 40x earnings, but forecast profit of $4.55B in 2027 cuts it to 34.7x

Intuitive Surgical (ISRG), maker of da Vinci surgical robots, trades at 40.0 times adjusted earnings over the last twelve months. Against forecast profit, the multiple looks lower: its $158 billion market value is 39.5 times expected fiscal 2026 net income of $3.99 billion, and 34.7 times fiscal 2027 net income of $4.55 billion. Consensus puts fiscal 2027 revenue at $13.3 billion, up 12.1%, slower than the 20.5% growth of the last twelve months. The forecast net margin of 34.1% is close to the 34% the company kept over that period. Risks include instrument pricing cuts of about 3% to 5% per procedure and higher spending. Management will give operating expense guidance in January.

LinkedIn
Oct 25th, 2026
Ruby Robotics Acquired by Intuitive for Minimally Invasive Care Solutions | Ruby Robotics posted on the topic | LinkedIn

We are excited to announce that in late 2025, Ruby Robotics was acquired by Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.   Together with Intuitive, we are continuing our mission to improve the accuracy, efficiency, and accessibility of tissue assessment during biopsy procedures at the point of care with integrated robotics and artificial intelligence solutions.   Thank you to our team, investors, advisors, consultants, and contributors whose shared belief in our vision made Ruby a success. To our new Intuitive colleagues: we’re excited to collaborate with you and look forward to making a positive impact on patients and physicians together. E14 Fund Root Ventures Link Ventures SeedFolio Kicker Ventures Celtic House Asia Partners Zelda Ventures Tamer Capital Taiwan Global Angels Cendana Capital UNION | 19 comments on LinkedIn

INACTIVE